HCV-话题@MedSci

#HCV#

247篇内容 | 3776人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257763, encodeId=4c65125e76357, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, objectType=article, longId=157446, objectId=175b15e44699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175b15e44699, replyNumber=0, likeNumber=72, createdTime=2019-01-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175b15e44699, moduleTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=175b15e44699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257762, encodeId=b658125e762ae, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异, objectType=article, longId=156075, objectId=86e41560e596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86e41560e596, replyNumber=0, likeNumber=69, createdTime=2018-12-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86e41560e596, moduleTitle=J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86e41560e596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257761, encodeId=b60b125e761dc, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Am J Transplant：HCV已故者肾脏供HCV阴性者进行移植具成本效果吗？, objectType=article, longId=154373, objectId=b0f71543e37a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0f71543e37a, replyNumber=0, likeNumber=69, createdTime=2018-11-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0f71543e37a, moduleTitle=Am J Transplant：HCV已故者肾脏供HCV阴性者进行移植具成本效果吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0f71543e37a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257760, encodeId=2fe1125e760e8, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Am J Transplant：肾移植前还是移植后进行HCV治疗又好又省钱？, objectType=article, longId=154372, objectId=fdb21543e200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdb21543e200, replyNumber=0, likeNumber=61, createdTime=2018-11-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdb21543e200, moduleTitle=Am J Transplant：肾移植前还是移植后进行HCV治疗又好又省钱？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdb21543e200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257759, encodeId=caa6125e7592e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=《2018年世界卫生组织慢性HCV感染的管理和治疗指南》摘译, objectType=article, longId=151373, objectId=d2bb1513e302, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2bb1513e302, replyNumber=0, likeNumber=48, createdTime=2018-10-20, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2bb1513e302, moduleTitle=《2018年世界卫生组织慢性HCV感染的管理和治疗指南》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2bb1513e302)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257758, encodeId=080f125e75859, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Structure：美国科学家揭示HCV病毒耐药的新机制, objectType=article, longId=151218, objectId=d49e151218f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d49e151218f8, replyNumber=0, likeNumber=50, createdTime=2018-10-18, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d49e151218f8, moduleTitle=Structure：美国科学家揭示HCV病毒耐药的新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d49e151218f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257757, encodeId=58b3125e7573e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=需不需要检测HCV？一看便知, objectType=article, longId=150638, objectId=9ceb150638ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ceb150638ac, replyNumber=0, likeNumber=75, createdTime=2018-10-10, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ceb150638ac, moduleTitle=需不需要检测HCV？一看便知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ceb150638ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257756, encodeId=54fa125e756c8, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Diabetes：复旦大学附属中山医院于明香教授团队研究：HCV感染使肾移植患者糖尿病风险增加3倍, objectType=article, longId=150299, objectId=616d150299d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616d150299d0, replyNumber=0, likeNumber=97, createdTime=2018-10-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616d150299d0, moduleTitle=J Diabetes：复旦大学附属中山医院于明香教授团队研究：HCV感染使肾移植患者糖尿病风险增加3倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616d150299d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257755, encodeId=754a125e7556a, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植患者，疗效显著且安全, objectType=article, longId=149345, objectId=898214934537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=898214934537, replyNumber=0, likeNumber=93, createdTime=2018-09-23, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=898214934537, moduleTitle=J Hepatol：Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植患者，疗效显著且安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=898214934537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257754, encodeId=245a125e7543c, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型, objectType=article, longId=147741, objectId=96b614e7416e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96b614e7416e, replyNumber=0, likeNumber=57, createdTime=2018-08-31, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96b614e7416e, moduleTitle=J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96b614e7416e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257753, encodeId=992f125e75341, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：采用Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植受者, objectType=article, longId=147738, objectId=506414e73818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=506414e73818, replyNumber=0, likeNumber=95, createdTime=2018-08-31, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=506414e73818, moduleTitle=J Hepatol：采用Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植受者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=506414e73818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257752, encodeId=b67a125e75254, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法, objectType=article, longId=147185, objectId=72b714e1854b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b714e1854b, replyNumber=0, likeNumber=59, createdTime=2018-08-23, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b714e1854b, moduleTitle=J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b714e1854b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257751, encodeId=22a3125e751b5, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=歌礼生物的Ravidasvir获得WHO HCV指南推荐, objectType=article, longId=146062, objectId=89ed146062de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ed146062de, replyNumber=0, likeNumber=75, createdTime=2018-08-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ed146062de, moduleTitle=歌礼生物的Ravidasvir获得WHO HCV指南推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89ed146062de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257750, encodeId=6730125e750ca, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：感染HCV后颈动脉粥样硬化根除病毒可否有所改善？, objectType=article, longId=145591, objectId=8a31145591f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a31145591f4, replyNumber=0, likeNumber=62, createdTime=2018-08-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a31145591f4, moduleTitle=J Hepatol：感染HCV后颈动脉粥样硬化根除病毒可否有所改善？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a31145591f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257749, encodeId=8605125e749aa, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, objectType=article, longId=145196, objectId=e18514519623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18514519623, replyNumber=0, likeNumber=84, createdTime=2018-07-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18514519623, moduleTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18514519623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257748, encodeId=9c52125e7485e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化, objectType=article, longId=145194, objectId=003414519441, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=003414519441, replyNumber=0, likeNumber=55, createdTime=2018-07-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=003414519441, moduleTitle=J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=003414519441)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257747, encodeId=5927125e7476d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：DAA治疗晚期肝纤维化的HCV患者，其新生HCC的发生率, objectType=article, longId=145191, objectId=71ff14519145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71ff14519145, replyNumber=0, likeNumber=63, createdTime=2018-07-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71ff14519145, moduleTitle=J Hepatol：DAA治疗晚期肝纤维化的HCV患者，其新生HCC的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71ff14519145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257746, encodeId=1b13125e74613, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, objectType=article, longId=142592, objectId=cd51142592a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd51142592a7, replyNumber=0, likeNumber=59, createdTime=2018-07-07, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd51142592a7, moduleTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd51142592a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257745, encodeId=a03b125e7459a, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：HCV患者获得SVR后，肝脏测试的持续变化并不少见；这与肝硬化和基线瞬时弹性成像数值相关, objectType=article, longId=142591, objectId=e3fa142591fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3fa142591fe, replyNumber=0, likeNumber=67, createdTime=2018-07-07, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3fa142591fe, moduleTitle=J Viral Hepat：HCV患者获得SVR后，肝脏测试的持续变化并不少见；这与肝硬化和基线瞬时弹性成像数值相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3fa142591fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257744, encodeId=4665125e7443e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：吉三代联合利巴韦林可提高HCV III型感染人群治愈率, objectType=article, longId=142217, objectId=3cac14221eb4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cac14221eb4, replyNumber=0, likeNumber=100, createdTime=2018-07-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cac14221eb4, moduleTitle=Gastroenterology：吉三代联合利巴韦林可提高HCV III型感染人群治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cac14221eb4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析

2019-01-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异

2018-12-19

ymljack (审核中...)

前往app查看评论内容

#HCV#

Am J Transplant：HCV已故者肾脏供HCV阴性者进行移植具成本效果吗？

2018-11-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

Am J Transplant：肾移植前还是移植后进行HCV治疗又好又省钱？

2018-11-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

《2018年世界卫生组织慢性HCV感染的管理和治疗指南》摘译

2018-10-20

ymljack (审核中...)

前往app查看评论内容

#HCV#

Structure：美国科学家揭示HCV病毒耐药的新机制

2018-10-18

ymljack (审核中...)

前往app查看评论内容

#HCV#

需不需要检测HCV？一看便知

2018-10-10

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Diabetes：复旦大学附属中山医院于明香教授团队研究：HCV感染使肾移植患者糖尿病风险增加3倍

2018-10-04

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植患者，疗效显著且安全

2018-09-23

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：在HCV患者抗病毒治疗后，开发出一种可以患者发生HCC风险的模型

2018-08-31

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：采用Sofosbuvir/velpatasvir治疗HCV基因1-4型肝移植受者

2018-08-31

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法

2018-08-23

ymljack (审核中...)

前往app查看评论内容

#HCV#

歌礼生物的Ravidasvir获得WHO HCV指南推荐

2018-08-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：感染HCV后颈动脉粥样硬化根除病毒可否有所改善？

2018-08-02

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险

2018-07-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化

2018-07-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：DAA治疗晚期肝纤维化的HCV患者，其新生HCC的发生率

2018-07-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素

2018-07-07

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：HCV患者获得SVR后，肝脏测试的持续变化并不少见；这与肝硬化和基线瞬时弹性成像数值相关

2018-07-07

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：吉三代联合利巴韦林可提高HCV III型感染人群治愈率

2018-07-04

科室
- - 订阅+
  - 更多科室
工具
服务